Paper - WANFANG MED ONLINE

You Position: Home > Paper

Computational Approaches to Analyze the Strategies of Drug Repositioning

( views:175, downloads:0 )

Author:: No author available

Journal Title:: Progress in Biochemistry and Biophysics

Issue:: 11

DOI:: 10.3724/SP.J.1206.2011.00558

Key Word:: 药物重定位;药物靶标;基因表达谱

Abstract：全新结构药物的研发存在周期长、耗资大、风险高的问题.通过各种技术预测已有药物的新适应症,即药物重定位,可以缩短药物研发时间、降低研发成本和风险.由于疾病种类和已知药物的数量繁多,完全通过实验筛选已知药物的新用途仍然具有很高的成本.随着组学和药物信息学数据的积累,药物重定位进入到了理性设计和实验筛选相结合的阶段,药物重定位的计算预测已经成为计算生物学和系统生物学的重要研究方向.本文将目前药物重定位计算分析的策略归纳为药物-靶标关系分析、药物-药物关系分析和药物-疾病关系分析,对已报道的技术方法及其成功应用实例进行了综述.

Reference

[1]易文渊,徐波,李敏,等.N糖基取代的沙利度胺新衍生物对人鼻咽癌细胞耐药逆转作用研究[J].2009,(1).
[2]谈效俊,张永新,钱敏平,等.芯片数据标准化方法比较研究[J].2007,(6).
[3]刘秀艳,谢正苗,陈惠哲.遗传基因组学（Genetical genomics）的研究进展[J].2006,(11).
[4]唐惠儒,王玉兰.代谢组学：一个迅速发展的新兴学科[J].2006,(5).
[5]李宁,吴松锋,朱云平,等.鸟枪法蛋白质鉴定质量控制方法研究进展[J].2009,(6).
[6]Michael, Kuhn,Monica, Campillos,Ivica, Letunic,etc.A side effect resource to capture phenotypic effects of drugs.[J].2010,6.
[7]Heng,Luo.DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome.[J].2011,39.
[8]Marina, Sirota,Joel T, Dudley,Jeewon, Kim,etc.Discovery and preclinical validation of drug indications using compendia of public gene expression data.[J].2011,3(96).
[9]CJ Bacchi,HC Nathan,SH Hutner,etc.Polyamine metabolism: a potential therapeutic target in trypanosomes[J].1980,210 (4467).
[10]Goh KI,Cusick ME,Valle D,etc.The human disease network[J].2007,104(21).
[11]Veach D,Christensen J,Chavan R,etc.Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases.[J].2005,11(7).
[12]孙汉昌,张纪阳,刘辉,等.串联质谱图谱从头测序算法研究进展[J].2010,(12).
[13]Caroline B, Ahlers,Dimitar, Hristovski,Halil, Kilicoglu,etc.Using the literature-based discovery paradigm to investigate drug mechanisms.[J].2007.
[14]Harrison, Charlotte.Drug repositioning: Genetic signatures uncover new uses.[J].2011,10(10).
[15]Joachim, von Eichborn,Manuela S, Murgueitio,Mathias, Dunkel,etc.PROMISCUOUS: a database for network-based drug-repositioning.[J].2011,39(Database issue).
[16]Pujol A,Mosca R,Farres J,etc.Unveiling the role of network and systems biology in drug discovery.[J].2010,31(3).
[17]Joel T, Dudley,Marina, Sirota,Mohan, Shenoy,etc.Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease.[J].2011,3.
[18]Lamb J.The Connectivity Map: a new tool for biomedical research.[J].2007,7(1).
[19]孙瑞祥,董梦秋,迟浩,等.基于电子捕获裂解/电子转运裂解串联质谱技术的蛋白质组学研究[J].2010,(1).
[20].Predicting new molecular targets for known drugs[J].2009,462(Nov.12 TN.7270).
[21]曹长姝,沈伟哉,李药兰,等.中药臭灵丹中3,5-二羟基-6,7,3',4'-四甲氧基黄酮对人鼻咽癌CNE细胞凋亡的影响及机制[J].2011,(3).
[22]Lamb J,Crawford ED,Peck D,etc.The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease[J].2006,313(5795).
[23]郭宗儒.药物的杂泛性[J].2011,(4).
[24]郭宗儒.老药在药物设计中的应用[J].2010,(3).
[25]Harold R. Garner,Raffi Bekeredjian,Jonathan D. Wren,etc.Knowledge discovery by automated identification and ranking of implicit relationships[J].2004,20(3).
[26]Kinnings, S.L.,Liu, N.,Tonge, P.J.,etc.A machine learning-based method to improve docking scoring functions and its application to drug repurposing[J].2011,51(2).
[27]Weeber M,Mons B,Kors JA.Online tools to support literature-based discovery in the life sciences[J].2005,6(3).
[28]R P, Warrell,S R, Frankel,W H, Miller,etc.Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).[J].1991,324(20).
[29]Deftereos S,Persidis A,Persidis A.Systems literature analysis.[J].2004,5(7).
[30]Saskia, Preissner,Katharina, Kroll,Mathias, Dunkel,etc.SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions.[J].2010,38(Database issue).
[31]Rein Vos,Marc Weeber,Lolkje T. W. de Jong-van den Berg,etc.Using concepts in literature-based discovery: simulating Swanson's raynaud-fish oil and migraine-magnesium discoveries[J].2001,52(7).
[32]Raoul, Frijters,Marianne, van Vugt,Ruben, Smeets,etc.Literature mining for the discovery of hidden connections between drugs, genes and diseases.[J].2010,6(9).
[33]Krantz, Allen.Diversification of the drug discovery process.[J].1998,16(13).
[34]Michaela, Spitzer,Emma, Griffiths,Kim M, Blakely,etc.Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.[J].2011,7.
[35]Iorio, F.,Bosotti, R.,Scacheri, E.,etc.Discovery of drug mode of action and drug repositioning from transcriptional responses.[J].2010,107(33).
[36]Bruce, Booth,Rodney, Zemmel.Quest for the best.[J].2003,2(10).
[37]Almen MS,Rask Andersen M,Schioth HB.Trends in the exploitation of novel drug targets.[J].2011,10(8).
[38]Loyda, Ylisastigui,Nancie M, Archin,Ginger, Lehrman,etc.Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression.[J].2004,18(8).
[39]Michael, Boyce,Kevin F, Bryant,Céline, Jousse,etc.A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress.[J].2005,307(5711).
[40]Ted T. Ashburn,Karl B. Thor.Drug Repositioning: Identifying and Developing New Uses for Existing Drugs[J].2004,3(8).
[41]蔡潭溪,刘平生,杨福全,等.脂质组学研究进展[J].2010,(2).
[42]Anne-Claude Gavin,Monica Campillos,Lars Juhl Jensen,etc.Drug Target Identification Using Side-Effect Similarity[J].2008,321(5886).
[43]刘伟,谢红卫.基于生物信息学方法发现潜在药物靶标[J].2011,(1).
[44]Vidal M,Barabasi AL,Yildirim MA,etc.Drug-target network.[J].2007,25(10).
[45]黄宏斌,梁芳,熊炜,等.生物信息技术加速开发旧药新用途[J].2012,(1).
[46]Robert A. Volkmann,Anton F. Fliri,William T. Loging.Analysis of System Structure-Function Relationships[J].2007,2(12).
[47]Zhang, M.,Jegga, A.G.,Sardana, D.,etc.Drug repositioning for orphan diseases[J].2011,12(4).
[48]De Jong Van Den Berg LT,Molema G,Weeber M,etc.Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide.[J].2003,10(3).
[49]Andronis, C.,Sharma, A.,Virvilis, V.,etc.Literature mining, ontologies and information visualization for drug repurposing[J].2011,12(4).
[50]Adams CP,Brantner VV.Estimating the cost of new drug development: is it really 802 million dollars?[J].2006,25(2).
[51]Ohashi K,Casey JL,Marion PL,etc.A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.[J].2002,76(20).
[52]Lei, Xie,Jian, Wang,Philip E, Bourne.In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators.[J].2007,3(11).